HedgeChatter

  • Home /
  • Tag Archives

biib

BIOGEN IDEC INC. Financials

moreView todays social media effects on BIIBView the latest stocks trending across Twitter. Click to view dashboardSee who Biogen is hiring next, click here to view […]

February 12, 2014 Bystocknews , Comments Off on BIOGEN IDEC INC. Financials read more

Apple, Twitter: Fund Managers Cool On Big Names

moreView todays social media effects on BIIBView the latest stocks trending across Twitter. Click to view dashboardSee who Biogen is hiring next, click here to view […]

February 11, 2014 Bystocknews , Comments Off on Apple, Twitter: Fund Managers Cool On Big Names read more

Potential Long Crude Oil Trade Set Up — Trading Concepts | E-Mini …

On today’s video I talk about a potential long trade set up in Crude Oil (@CL or ETF USO) and in the stock Kimberly-Clark (KMB). I also show you where I was stopped out with a profit in the Biogen (BIIB) trade – be sure to watch the video for all the details and hope the video helps.Be sure to […]

January 10, 2014 ByTodd Mitchell , , , , , , , , , , , Comments Off on Potential Long Crude Oil Trade Set Up — Trading Concepts | E-Mini … read more

The Lancet Publishes SELECT Study Evaluating Efficacy and Safety of Daclizumab HYP in Multiple Sclerosis

[Business Wire] – WESTON, Mass.–(BUSINESSWIRE)– Today Biogen Idec (NASDAQ: BIIB) announced that results from the daclizumab high-yield process (DAC HYP) SELECT clinical trial have been published as an online article in … moreView todays social media effects on BIIBView the latest stocks trending across Twitter. Click to view dashboardSee who Biogen is hiring next, click here to view […]

April 4, 2013 Bystocknews , Comments Off on The Lancet Publishes SELECT Study Evaluating Efficacy and Safety of Daclizumab HYP in Multiple Sclerosis read more

CHMP Issues Positive Opinion for TECFIDERAâ„¢ (Dimethyl Fumarate) as a First-Line Treatment for Multiple Sclerosis in the European Union

[Business Wire] – WESTON, Mass.–(BUSINESSWIRE)– Today Biogen Idec (NASDAQ: BIIB) announced that it has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) in the European Union (EU) … moreView todays social media effects on BIIBView the latest stocks trending across Twitter. Click to view dashboardSee who Biogen is hiring next, click here to view […]

March 22, 2013 Bystocknews , Comments Off on CHMP Issues Positive Opinion for TECFIDERAâ„¢ (Dimethyl Fumarate) as a First-Line Treatment for Multiple Sclerosis in the European Union read more

NEW PHASE 3 DATA REINFORCE LONG-LASTING PROTECTION FROM BLEEDING FOR PATIENTS WITH HEMOPHILIA A AND B

[at noodls] – More news 2013-02-08 Sobi Press Release on February 8, 2013, in PDF format BIOGEN IDEC CONTACT: Media Contact: Jeff Boyle +1-781-464-3260 Investor Relations Contact: Kia Khaleghpour Ph: +1-781-464-2442 … moreView todays social media effects on BIIBView the latest stocks trending across Twitter. Click to view dashboardSee who Biogen is hiring next, click here to view […]

February 8, 2013 Bystocknews , Comments Off on NEW PHASE 3 DATA REINFORCE LONG-LASTING PROTECTION FROM BLEEDING FOR PATIENTS WITH HEMOPHILIA A AND B read more